Searched for
STEVEN NISSEN
'Desperation science' slows the hunt for coronavirus drugsDesperate to solve the deadly conundrum of COVID-19, the world is clamouring for fast answers and solutions from a research system not buil...- US Food and Drug Administration approves drug to cut cholesterolMorgan Liscinsky, an FDA spokeswoman, said high levels of LDL cholesterol were a known risk factor for heart disease.
- Panel suggests Glaxo's Avandia can stayGlaxoSmithKline's shares surge after a panel of US doctors votes to keep the diabetes pill Avandia on the market.
- Safety scare over Glaxo drug fuels talks of tougher laws in USLaw makers are seizing on last month’s study linking GlaxoSmithKline’s diabetes drug Avandia and heart risks to press for new US drug-safet...
- Glaxo failed to publicise Avandia risksGlaxoSmithKline was the drug industry’s top advertiser last year, promoting its asthma and diabetes treatments to patients and doctors. Inf...
- New study adds to worries about diabetes drug classAnother study has found that diabetes drugs intended to help patients live longer, healthier lives may in fact increase the chances they wi...
- Pfizer may cut jobs, rejig biz to tide over crisisPfizer will likely slash staff and accelerate merger and licencing deals as the pressure on it to improve its financial performance intensi...
- Pfizer halts cholesterol drug trial, shares may take a hitPfizer’s shares will likely plunge after the world’s biggest drugmaker unexpectedly ended development of its most important new drug, a cho...
- Merck's Vioxx successor equally risky, finds studyMerck & Co’s experimental painkiller, Arcoxia, may carry the same risk of heart attacks and strokes as Vioxx, according to an analysis of 2...
Load More- Safety scare over Glaxo drug fuels talks of tougher laws in US
